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The CAMP response element (CRE) and the CCAAT box of the fibronectin gene promoter are separated by only twenty base pairs. A specific 
factor that binds the CRE interacts cooperatively with the protein which bmds to the adjacent CCAAT box, sttmulatmg transcription [1992. J. 
Biol. Chem. 267, 127677127741. Here we show that the CRE factor IS an heterodimer between a 43 kDa and the ‘73 kDa’ CRE-binding proteins 
and we identify the latter as ATF-2 (also named CRE-BPI). a protein implicated in recrmtmg transcriptional activators to promoters, able to form 
heterodimers with Jun and for which a sequence-deduced MW of 55 kDa had been previously reported. 
CRE: CAAT box; Fibronectm gene promoter: ATF-2 
1. INTRODUCTION 
The expression of fibronectin (FN). the multifunc- 
tional-multidomain adhesive glycoprotein [ 1,2], is regu- 
lated at the transcriptional level by cyclic AMP [335]. 
Cyclic AMP-dependent phoshorylations activate mem- 
bers of the CREB/ATF family of DNA binding proteins 
[68]. This family includes polypeptides encoded by at 
least seven distinct genes [6,9], that share the ability to 
bind, with different affinities, to the CRE (cyclic AMP 
response element, 5’-TGACGTA-3’) present in the pro- 
moter regions of genes activated by CAMP [lo-131. A 
wide range of CREB/ATF dimers can be formed as a 
consequence of the diversity of monomers. This diver- 
sity is not only generated by gene multiplicity, but also 
by alternative splicing [14], the degree of phosphoryla- 
tion and the possibility to form heterodimers with the 
structurally related members of the Jun and Fos families 
[15,16]. 
In the FN gene promoter the CRE and the CCAAT 
box are separated by only twenty base pairs, i.e. two 
turns of double helix. We have recently demonstrated 
that there is a molecular interaction between the liver 
transcription factors that bind to these two elements 
and that this interaction stimulates transcription [ 171. 
We have also shown that the binding to the FN-CRE 
of a factor having a 73 kDa CRE-binding polypeptide, 
but lacking CCAAT-binding activity, acts coopera- 
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tively on the occupation of the adjacent CCAAT box by 
its corresponding factor [17]. Here we show that the 73 
kDa CRE-binding protein is ATF-2 (also named CRE- 
BPI), a factor implicated in recruiting transcriptional 
activators to promoters [18] and for which a sequence- 
deduced MW of 55 kDa had been reported [12]. 
2. MATERIAL AND METHODS 
2.1. Protein rutructs 
Nuclei were isolated from perfused liver of male Sprague-Dawley rats 
weighing 180-200 g, as described [19]. Nuclear proteins were extracted 
according to Dignam et al. [20]. 
2.2. In Vitro trunscription and translatron 
‘S-labeled ATF-2 was synthesized in vitro by transcription of ATF- 
2 cDNA by usmg T7 RNA polymerase (Boehringer) and subsequent 
translation in rabbtt rettculocyte lysate (Promega) according to the 
manufacturers’ instructions. 
2.3. Gel retardutlon assays 
These were performed with nuclear extracts (up to 5pg) or reticulo- 
cyte translation mixtures (1 pl), usmg the FN-CRE oligonucleottde as 
previously described [21,22]. 
2.4. Southwestern blots 
Conditions for the transfer of proteins to nitrocellulose membranes. 
renaturation and binding to labeled ohgonucleotides were those previ- 
ously described [22]. 
2.5. UV-crosslinhwg 
Protein/“P-oligonucleotide complexes were covalently cross-linked 
by irradiating the retardation gels with light of 254 nm for 30 min [23]. 
Following autorradiography, the identified bands were excised from 
gels, triturated and boiled for 5 min in 50 ~1 ‘Laemmli’ buffer Eluted 
complexes were separated from polyacrylamtde by centrifugatton over 
plastic columns with a porous bottom, and run in SDSlO% poly- 
acrylamide gel electrophoresis. 
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3. RESULTS 
The FN-CRE oligonucleotide forms complexes with 
two factors present in liver nuclear extracts: the low 
mobility complex a, and the high mobility complex b 
(Fig. lA, lane 1). Both CRE-binding factors can be 
separated by chromatography on Mono Q. The factor 
forming complex a (fraction 15, fig. lA, lane 3) elutes 
at lower ionic strength than the factor forming complex 
b (fraction 23, Fig. lA, lane 3). As we have shown 
before [ 171, though fraction 23 has no CCAAT-binding 
activity per se, it acts cooperatively on the occupation 
of the CCAAT box of the FN gene promoter (Fig. 1B). 
Southwestern blots revealed that complexes a and b are 
associated with CRE-binding polypeptides of 43 and 73 
kDa, respectively [ 171. A model based on these observa- 
tions is shown in Fig. 1C. 
3.1. U V crosslinking 
Protein/3”P-DNA crosslinking studies suggested that 
complex b contains a CRE-binding polypeptide of 
higher MW than the 43 kDa one present in the slow 
migrating complex n. An SDS-PAGE of the linked com- 
plexes excised from native gels is shown in Fig. 2. Com- 
plex b presents bands of approximately 80 and 50 kDa 
(lane 2), which would correspond to polypeptides of 72 
and 42 kDa if an oligonucleotide mass contribution of 
about 8 kDa is assumed (26 nucleotides. 0.3 kDa each). 
On the other hand, complex a presents bands of lower 
MW, i.e. approximately 50 and 43 kDa (lane 1), which 
in turn would correspond to polypeptides of 42 and 35 
kDa. 
3.2. SDS-PAGE of recombinant and natural ATF-2 
In our previous work [17] the 73 kDa polypeptide was 
thought to be a novel CRE-binding protein, since no 
CRE factor of such molecular weight had been previ- 
ously reported [6,9.12,24]. However. since a full length 
cDNA clone for ATF-2 (CRE-BPI) had been isolated 
using as probe the CRE sequence of the FN gene pro- 
moter [12], we decided to investigate whether this factor, 
of deduced MW = 55 kDa, was related to the 73 kDa 
protein identified by UV crosslinking. Surprisingly, re- 
combinant ATF-2 showed an apparent MW of 73 kDa 
in SDS-PAGE (Fig. 3, lanes 1 and 2). Consistently, an 
anti-hATF-2 antiserum recognizes bands that co-mi- 
grate with recombinant ATF-2 in Western blots of 
HeLa (lane 3) and rat liver (lane 4) nuclear extracts, as 
well as with the ‘73 kDa’ band in the liver Southwestern 
(lane 5). 
3.3. Effect of anti-hATF-2 untiserum on complex b 
In gel retardation experiments performed with in 
vitro-translated hATF-2, no complexes of similar mo- 
bility to complex b were detected. Instead, a band corre- 
sponding to the ATF-2 homodimer, and of lower mobil- 
ity than complex a is specifically lost in the presence of 
26 
C 
Fig. 1 (A) Gel retardation assays of binding of the FN-CRE oligonu- 
cleotide to unfractionated liver nuclear extract (lane l), and Mono Q 
fractions 15 (lane 2) and 23 (lane 3). (B) Effect of the additton of 
mcreasmg amounts of fractton 23 to a constant amount of frdctton 15 
on the fracttonal occupatton cf, of the fibronectin gene CCAAT box 
Factorfwas calculated as descrtbed [I 71. (C) Model for a cooperative 
effect of a factor contammg the 73 kDa CRE bindmg protem on the 
bmdmg to the adjacent CCAAT box in the fibronectin gene. 
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Fig. 2. UV-crosslinking of FN-CRE complexes. The “P end-labeled 
FN-CRE ohgonucleotide was Incubated wtth liver nuclear extract 
followmg the condittons for a typical retardation assay. Upon electro- 
phoresis. complexes (I (lane 1) and h (lane 7) were covalently 
crosslinked, excised. denatured and subjected to SDS-PAGE as de- 
scribed m sectton 2. 
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anti-ATF-2 antiserum (Fig. 4, lanes 14). Since the anti- 
hATF-2 antiserum reacts weakly with rat liver ATF-2 
(compare lanes 3 and 4 in Fig. 3) we first determined 
which FN-CRE binding proteins were affected by incu- 
bation with this antiserum in a human nuclear extract. 
As rat liver, extracts of human HeLa cells generate 
complexes a and b in gel retardation assays. Fig. 4 (lanes 
5-7) shows that HeLa complex b consists, at Ieast in 
part, of ATF-2, as demonstrated by the loss of one of 
its bands in the presence of anti-hATF-2 antiserum but 
not with non-immune serum. Complex u was unaffected 
by either sera, indicating that ATF-2 is not part of it. 
Similar results were obtained when rat liver nuclear 
extracts were assayed for binding in the presence of the 
anti-ATF-2 antibody (Fig. 4, lanes 8-10). In this case, 
the complex b was ‘supershifted’ by the specific antise- 
rum. These results indicate that the 73 kDa polypeptide 
detected in complex b, both by Southwesterll and by 
UV-crosslinking, is ATF-2. 
DISCUSSION 
In this study, ATF-2 was identified as the ‘73 kDa’ 
polypeptide present in an heterodimeric CRE binding 
factor that facilitates the occupation of the adjacent 
CCAAT sequence in the fibronectin gene promoter. 
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Fig. 3. SDS-polyac~Iamide gel electrophoresis of recombinant and 
natural ATF-2. Lanes 1 and 2: [%]methionine-labeled proteins ob- 
tained in rabbit reticulocyte lysates incubated in the absence (lane 1) 
or in the presence (lane 2) of T7 polymerase-synthestzed ATF-2 
mRNA. Lanes 3 and 4: Western blot of HeLa (lane 3) and rat liver 
(lane 4) nuclear extracts probed with an anti-human ATF-2 antiserum. 
Lane 5, Southwestern blot analysis of the rat liver nuclear extract of 
lane 4. probed with the “P-labeled FN-CRE ohgonucleottde. 
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fg. 4. Effect of the anti ATF-2 antiserum on FN-CRE complexes. Gel retardation assays were performed with ~programm~ (lane 1 f or ATF-2 
mRNA-programmed (lanes 224) rabbit rettculocyte lysates. HeLa nuclear extracts (lanes 5-7) and liver nuclear extracts (lanes g-10). One ,uI of 
rabbit non-immune (lanes 3. 7 and 10) or anti ATF-2 (lanes 4, 6 and 9) crude anttsera were added to the pre-incubation mixtures. Non-specific 
CRE-bmding activities present m the ATF-2 antiserum and in the rabbit rettculocyte lysate produced bands which are marked with stars and open 
triangles, respectively. 
27 
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Identification is supported by three experiments. (i) Pro- 
tein/DNA crosslinking showed that the liver factor is 
composed of CRE binding polypeptides with SDS- 
PAGE MW of approximately 73 kDa and 43 kDa. (ii) 
Recombinant ATF-2 co-migrates in SDS-PAGE with 
the 73 kDa polypeptide of liver nuclear extracts detected 
by both a specific anti-ATF-2 antiserum and 32P-la- 
beled FN-CRE oligonucleotide. (iii) The anti-hATF-2 
antiserum specifically interferes with the formation of 
the gel retardation complex b, having the 73 kDa pol- 
ypeptide. 
ATF-2 (CRE-BPl) is a ubiquitously expressed CRE 
binding protein of cDNA with deduced MW of 55 kDa 
[ 121. However, it migrates in SDS-PAGE with an appar- 
ent MW of 73 kDa (this report). The protein contains, 
at its C-terminus, leucine zipper motifs similar to those 
found in other enhancer binding proteins such as 
CREB, c/EBP and AP-1 (Jun/Fos). Recently, two 
shorter forms of CREBP-1 (named CRE-BP2 and 3) 
have been characterized [25]. The three isoforms are the 
result of differential splicing and transcriptional initia- 
tion. In expression studies of the T-cell receptor com- 
plex CD3 6 gene. while CRE-BP2 and 3 were potent and 
weak activators. respectively, CRE-BP1 was transcrip- 
tionally inert per se [25]. These findings reinforce the 
idea that ATF-YCRE-BP1 acts as a specific DNA bind- 
ing protein that recruits, by proteinprotein interac- 
tions, other factors which provide activation domains 
necessary for transcriptional stimulation. In fact, Liu 
and Green [ 181 also found that ATF-2 is transcription- 
ally inert but becomes a potent transactivator when 
coexpressed with the adenovirus Ela protein. which 
lacks DNA binding domains. On the other hand, ATF- 
2 is able to form heterodimers with the 43 kDa Jun 
polypeptide [ 16,261. 
The liver FN-CRE binding factor of complex b stud- 
ied here is a heterodimer between ATF-2 and a 43 kDa- 
polypeptide (Figs. 2 and 4). Besides, its cooperative 
effect on the occupation of the CCAAT box is presum- 
ably due to proteinprotein interactions with a still un- 
identified CCAAT-binding protein [ 171. These features 
are consistent with the above mentioned ability of ATF- 
2 to heterodimerize with Jun and to interact with other 
transcription factors. As protein dimerization and pro- 
tein-protein interactions are of relevance in transcrip- 
tional regulation, it now becomes crucial to identify the 
particular CCAAT binding protein that binds the 
CCAAT box of the fibronectin gene and determine 
whether it actually interacts with the ATF-2-containing 
complex b. and to investigate the putative interaction of 
this complex with the basic transcription machinery. 
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